Optimal (18F)FDG PET/CT cutoff for pathologic complete response in HER2-positive early breast cancer patients treated with neoadjuvant trastuzumab and pertuzumab in the PHERgain tr...
by Gebhart, Geraldine (Author)
, Keyaerts, Marleen (Author)
, Guiot, Thomas (Author)
, Flamen, Patrick (Author)
, Ruiz-Borrego, Manuel (Author)
, Stradella, Agostina (Author)
, Bermejo, Begoña (Author)
, Escriva-de-Romani, Santiago (Author)
, Martínez, Lourdes Calvo (Author)
, Ribelles, Nuria (Author)
, Fernandez-Abad, María (Author)
, Albacar, Cinta (Author)
, Colleoni, Marco (Author)
, Garrigos, Laia (Author)
, Frutos, Manuel Atienza de (Author)
, Dalenc, Florence (Author)
, Prat, Aleix (Author)
, Marmé, Frederik (Author)
, Schmid, Peter (Author)
, Kerrou, Khaldoun (Author)
, Braga, Sofia (Author)
, Gener, Petra (Author)
, Sampayo-Cordero, Miguel (Author)
, Cortés, Javier (Author)
, Pérez-García, José Manuel (Author)
, Llombart-Cussac, Antonio (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource